In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Felicita Andreotti
Speaker
Felicita Andreotti
Felicita Andreotti Felicita Andreotti

Fondazione Policlinico Universitario Gemelli IRCCS, Catholic University, Rome (Italy)

Specialities : General Cardiology , Acute Coronary Syndromes, Pharmacology and Pharmacotherapy

24 presentations from this speaker

A DOAC is always indicated in the acute phase of PE - PRO.

Event : Acute Cardiovascular Care 2019

  • Session : Old and new anticoagulants in acute pulmonary embolism: looking for the best?
  • Speaker : F Andreotti (Rome,IT)
  • Joint session with the ESC Working Group on Thrombosis

A DOAC is always indicated in the acute phase of PE - Rebuttal.

Event : Acute Cardiovascular Care 2019

  • Session : Old and new anticoagulants in acute pulmonary embolism: looking for the best?
  • Speaker : F Andreotti (Rome,IT), F Verheugt (Amsterdam,NL)
  • Joint session with the ESC Working Group on Thrombosis

Aspirin in patients with diabetes: primary prevention, secondary prevention or both?

Event : ESC Congress 2019

  • Session : Translating data to practice: aspirin in high-risk patient subgroups
  • Speaker : U Laufs (Leipzig,DE), F Andreotti (Rome,IT)
  • Sponsored by Bayer AG

Looking beyond patient age: the role of aspirin in cardiovascular risk management

Event : ESC Congress 2019

  • Session : Translating data to practice: aspirin in high-risk patient subgroups
  • Speaker : F Andreotti (Rome,IT), U Laufs (Leipzig,DE)
  • Sponsored by Bayer AG

Optimal medical treatment for chronic coronary syndrome.

Event : ESC Congress 2019

  • Session : Chronic coronary syndrome: Essential Update
  • Speaker : F Andreotti (Rome,IT)

Panel discussion

Event : ESC Congress 2019

  • Session : Benefits and risks of anticoagulation in elderly atrial fibrillation patients
  • Speaker : F Andreotti (Rome,IT)
  • Sponsored by Daiichi Sankyo Europe GmbH

Welcome and introduction

Event : ESC Congress 2019

  • Session : Benefits and risks of anticoagulation in elderly atrial fibrillation patients
  • Speaker : F Andreotti (Rome,IT)
  • Sponsored by Daiichi Sankyo Europe GmbH

Anticoagulation should replace antiplatelets in CAD prevention - PRO

Event : ESC Congress 2018

  • Session : The great debate: thrombocardiology post COMPASS.
  • Speaker : F Andreotti (Rome,IT)
  • Great Debate

Anticoagulation should replace antiplatelets in CAD prevention - Rebuttal PRO.

Event : ESC Congress 2018

  • Session : The great debate: thrombocardiology post COMPASS.
  • Speaker : F Andreotti (Rome,IT)
  • Great Debate

NOACs in kidney failure: why, how, when and when not?

Event : ESC Congress 2017

  • Session : The use of oral anticoagulants in special situations
  • Speaker : F Andreotti (Rome,IT)

NSTE-ACS: how are women different, if at all?

Event : ESC Congress 2017

  • Session : Practical aspects of care in Non-ST-Elevation-ACS
  • Speaker : F Andreotti (Rome,IT)
  • Joint with the Cardiological Society of India

Antiplatelet treatment in atrial fibrillation patients under going PCI - What do the Guidelines say?

Event : ESC Congress 2016

  • Session : 2015 NSTE - Acute coronary syndromes Guidelines in daily practice
  • Speaker : F Andreotti (Rome,IT)

Does age matters?

Event : ESC Congress 2016

  • Session : Acute coronary syndromes in the very elderly
  • Speaker : F Andreotti (Rome,IT)

Improving patient care with NOACs – Where are we now?

Event : ESC Congress 2016

  • Session : Oral anticoagulation, thrombosis and bleeding – Improving patient care with NOACs
  • Speaker : F Andreotti (Rome,IT)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Optimising patient care with NOACs – Panel discussion.

Event : ESC Congress 2016

  • Session : Oral anticoagulation, thrombosis and bleeding – Improving patient care with NOACs
  • Speaker : H Darius (Berlin,DE), F Andreotti (Rome,IT)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

State of the art in tailoring antithrombotics according to bleeding risk.

Event : ESC Congress 2016

  • Session : Tailoring antithrombotics according to bleeding risk
  • Speaker : F Andreotti (Rome,IT)

Troponin - The grey zone - Conclusion and take home message

Event : ESC Congress 2016

  • Session : NSTEMI - I came, I diagnosed, I treated
  • Speaker : F Andreotti (Rome,IT)

Dual therapy without aspirin.

Event : ESC Congress 2015

  • Session : Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome
  • Speaker : F Andreotti (Rome,IT)

Future direction for research in antithrombotics.

Event : ESC Congress 2015

  • Session : Antithrombotic drugs - An ongoing research
  • Speaker : F Andreotti (Rome,IT)

NSTEMI and atrial fibrillation - What do the Guidelines say?

Event : ESC Congress 2015

  • Session : NSTEMI guidelines: helpful in the real world?
  • Speaker : F Andreotti (Rome,IT)

Special populations and conditions.

Event : ESC Congress 2015

  • Session : ESC Guidelines - Acute Coronary Syndromes Non-ST-Elevation
  • Speaker : F Andreotti (Rome,IT)

Women.

Event : ESC Congress 2015

  • Session : Optimising management of acute coronary syndromes in different patient subgroups
  • Speaker : F Andreotti (Rome,IT)

Challenges in the management of atrial fibrillation - Take home message & what do the guidelines say?

Event : ESC Congress 2013

  • Session : Challenges in the management of atrial fibrillation
  • Speaker : F Andreotti (Rome,IT)

Warfarin and proton pump inhibitors.

Event : ESC Congress 2013

  • Session : The heart and the gut. The use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
  • Speaker : F Andreotti (Rome,IT)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are